Quantitative Investment Management’s Axsome Therapeutics AXSM Stock Holding History

Quantitative Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$344K	Sell	2,040 -484	-19%	-$83.6K	0.04%	332
2025 Q4	$460K	Buy	2,524 +429	+20%	+$59.9K	0.04%	322
2025 Q3	$254K	Buy	+2,095	New	+$236K	0.04%	299
2025 Q2	–	Sell	-5,259	Closed	-$613K	–	319
2025 Q1	$613K	Buy	+5,259	New	+$599K	0.06%	236
2024 Q4	–	Sell	-8,231	Closed	-$739K	–	327
2024 Q3	$739K	Sell	8,231 -3,568	-30%	-$311K	0.07%	196
2024 Q2	$949K	Buy	+11,799	New	+$874K	0.1%	164
2024 Q1	–	Sell	-10,138	Closed	-$806K	–	248
2023 Q4	$806K	Buy	+10,138	New	+$678K	0.05%	264
2023 Q3	–	Sell	-15,300	Closed	-$1.1M	–	181
2023 Q2	$1.1M	Buy	+15,300	New	+$1.13M	0.1%	171

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantitative Investment Management's AXSM Position: Q1 2026 in Review

Quantitative Investment Management reduced its Axsome Therapeutics (AXSM) stake by 19% in Q1 2026, selling an estimated $83.6K and leaving 2,040 shares worth $344K. The position accounts for 0.04% of the portfolio, ranked #332.

Quantitative Investment Management first reported a position in AXSM in Q2 2023 and has held it in 8 quarters since. The position peaked at $1.1M in Q2 2023. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Quantitative Investment Management held 2,040 shares of Axsome Therapeutics worth $344K as of Q1 2026.
Quantitative Investment Management sold 484 Axsome Therapeutics shares in Q1 2026, an estimated $83.6K.
Axsome Therapeutics made up 0.04% of Quantitative Investment Management's portfolio in Q1 2026, its #332 holding.
Quantitative Investment Management first reported a position in Axsome Therapeutics in Q2 2023 and has held it in 8 quarters since.
Quantitative Investment Management's Axsome Therapeutics position peaked at $1.1M in Q2 2023.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Quantitative Investment Management's 13F filing for Q1 2026, filed 15 May 2026.